Health

Scientists Capture First Glimpse Of Parkinson’s ‘Trigger’ In Human Brain

Researchers have made a landmark discovery by capturing the first direct glimpse of protein clumps in human brain tissue, long suspected to spark Parkinson’s disease, opening fresh possibilities for understanding the roots and early progression of the disorder.

The international study, led by teams from the University of Cambridge and University College London, relied on a new method known as ASA-PD (Advanced Sensing of Aggregates for Parkinson’s Disease).

This technique combines advanced fluorescence microscopy with ultra-sensitive detection tools, making it possible to observe alpha-synuclein oligomers, microscopic protein clusters that had previously remained invisible.

Parkinson’s Protein Clumps Revealed

Oligomers are just a few nanometres long, so weak in signal that they were once described as the ‘needle in a haystack’ of brain research.

ASA-PD changes that by amplifying their signals while filtering out background noise, allowing scientists to map and analyse millions of them in post-mortem brain samples.

“It’s like suddenly being able to see stars in daylight,” said Dr Rebecca Andrews, who carried out much of the work while at Cambridge’s Yusuf Hamied Department of Chemistry.

When comparing tissue from people with Parkinson’s to that of healthy donors, the researchers noticed striking differences.

The study revealed oligomers in both healthy and Parkinson’s brains, but in patients, they were bigger, brighter and more frequent.

Importantly, scientists identified a subclass exclusive to Parkinson’s, possibly serving as the earliest biological marker of the disease.

“This gives us a map of where to look and what to target,” explained Professor Lucien Weiss of Polytechnique Montréal, who co-led the project.

The study, featured in Nature Biomedical Engineering, suggests a path toward earlier detection and tailored treatments for Parkinson’s.

Because protein clumps drive other brain conditions, the method could also benefit Alzheimer’s and Huntington’s research.

The discovery provides the first real window into the origins of Parkinson’s, potentially revolutionising efforts to combat neurodegenerative conditions across the world in the years ahead.

Also Read: Excess Carbs And Saturated Fats Driving Health Crisis In India, Says ICMR Research

Pragati Upadhyay

I report stories and occasionally rescue facts from chaos. By profession, I’m a journalist; by conviction, a social worker who believes words should move people, not just headlines. I question power, celebrate ordinary heroes, and sometimes irritate the comfortable. If truth had a shift, I’d probably be working overtime.

Recent Posts

Samadhan Abhiyan Study Finds Only 17% Understand POCSO Law Properly

Samadhan Abhiyan’s Annual Day 2026 study found that only 17 per cent of people understand…

38 mins ago

Sensex Ends Four Day Losing Streak On Global Gains

Indian indices ended a four-day losing streak, with the Sensex rising 473 points and Nifty…

1 hour ago

India, Switzerland Set To Expand Strategic Partnership Across Key Sectors

Prime Minister Narendra Modi and Swiss President Guy Parmelin held talks in New Delhi on…

2 hours ago

2026 Nobel Medicine Prize Honours Trio For Optogenetics Transforming How Scientists Study The Brain

Karl Deisseroth, Peter Hegemann and Georg Nagel won the 2026 Nobel Medicine Prize for pioneering…

2 hours ago

PM Modi Says India, Switzerland Back Global Reforms For Peace & Stability

Prime Minister Narendra Modi said India and Switzerland support global institutional reforms to address challenges…

3 hours ago

PM Modi Says India, Switzerland Back Global Institutional Reforms To Address Growing Global Challenges

Prime Minister Narendra Modi said India and Switzerland support institutional reforms to tackle global challenges…

3 hours ago